SEC under pressure as OIG probe could reveal crypto conflicts. Could this impact XRP’s legal battle and price outlook? Read ...

Cboe files to list XRP ETFs from Bitwise, 21Shares, and others, as Polymarket sets approval odds for 2025 at 80%.

Is altcoin season potential still alive or running out of steam? XRP ETF filings flood in, and more: Hodler’s Digest ...

Meanwhile, PlutoChain ($PLUTO) offers a hybrid Layer-2 solution that could speed up Bitcoin transactions and potentially ...

With XRP's (CRYPTO: XRP) price rising by 256% in the last three years alone, it's a bit surprising that there's still a ...

As Solana (SOL) and XRP exhibit limited growth potential, investors are turning to IntelMarkets (INTL), an AI-driven altcoin ...

From Trump tariffs to XRP ETFs and major Coinbase listings, this week in crypto saw pivotal market developments shaping the sector's future.

Institutional crypto adoption advances as Franklin Templeton gains SEC approval for its Crypto Index ETF, offering a regulated gateway into digital assets.

XRP price rallies amid ETF buzz, but SEC appeal uncertainty remains a key risk. What’s next for XRP? Get expert analysis.

Trumps re-election brings optimism to the crypto market, with Bitcoin surpassing $100K and institutional interest rising.

Cboe has filed 19b-4 forms with the SEC for four XRP ETFs, kicking off a 240-day review process. Could new SEC leadership ...

Entero Therapeutics, Inc. (Nasdaq: ENTO) ("Entero” or the "Company”), a clinical-stage biopharmaceutical company specializing ...